Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular CarcinomaAlexis Bujold, Laura A. Dawson, Christine Massey et al.|Journal of Clinical Oncology|2013Cited by 830
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw Aung, Jennifer J. Knox, Amy Zhang et al.|Clinical Cancer Research|2017Cited by 635
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaLaura A. Dawson, M. Hawkins, Gina Lockwood et al.|Journal of Clinical Oncology|2008Cited by 597
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J. Knox, Grainne M. O’Kane|Nature Communications|2025Cited by 21
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trialsZainul Abedin Kapacee, Mairéad G. McNamara, Jennifer J. Knox et al.|Medical Oncology|2020Cited by 15